An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

Steven A. Roberts(National Institute of Environmental Health Sciences), Michael S. Lawrence(Broad Institute), Leszek J. Klimczak(National Institute of Environmental Health Sciences), Sara A. Grimm(National Institute of Environmental Health Sciences), David C. Fargo(National Institute of Environmental Health Sciences), Petar Stojanov(Broad Institute), Adam Kieżun(Broad Institute), Gregory V. Kryukov(Broad Institute), Scott L. Carter(Broad Institute), Gordon Saksena(Broad Institute), Shawn Harris(SRA International (United States)), Ruchir Shah(SRA International (United States)), Michael A. Resnick(National Institute of Environmental Health Sciences), Gad Getz(Broad Institute), Dmitry A. Gordenin(National Institute of Environmental Health Sciences)
Nature Genetics
July 14, 2013
10.1038/ng.2702
Cited by 1,211Open Access
Full Text

Abstract

Related Papers

Mutator phenotype may be required for multistage carcinogenesis.
L A Loeb|PubMed|1991|1.3k
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Simon Forbes, Gurpreet Bhamra, Sally Bamford et al.|Current Protocols in Human Genetics|2008|918
APOBEC3B is an enzymatic source of mutation in breast cancer
Michael B. Burns, Lela Lackey, Michael A. Carpenter et al.|Nature|2013|874
Evolution of the cancer genome
Lucy Yates, Peter J. Campbell|Nature Reviews Genetics|2012|659
S-phase checkpoint proteins Tof1 and Mrc1 form a stable replication-pausing complex
Yuki Katou, Yutaka Kanoh, Masashige Bando et al.|Nature|2003|653